Dong-A exports new antibiotic to US

Published: 2007-03-02 06:57:00

Updated: 2007-03-02 06:57:00

Dong-A Pharmaceutical Co., the nation's largest drugmaker, said on February 27 that it had signed a contract with the U.S.-based Trius Therapeutics in San Diego, for the development and marketing of a novel antibiotic (DA-7278) worldwide.

DA-7157, oxazolidinone antibiotic, showed four fold bet...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK